Trials in Raleigh, North Carolina
Here are the top 10 medical studies for alzheimer's disease in Raleigh, North Carolina
Popular Filters
Phase 3 Trials
Monoclonal Antibodies
Donanemab for Alzheimer's Disease
Recruiting1 awardPhase 3
Kinston, North Carolina
This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
Monoclonal Antibodies
Donanemab for Early Alzheimer's Disease
Recruiting1 awardPhase 3
Washington, District of Columbia
This trial is testing donanemab, a drug for early Alzheimer's disease. It targets people with early symptoms and specific brain changes. The drug helps remove harmful proteins from the brain, potentially slowing down or improving symptoms.
Trials With No Placebo
Behavioral Intervention
Advance Care Planning for Alzheimer's and Dementia
Recruiting1 award1 criteria
Chapel Hill, North Carolina
This trial will test a toolkit called Dementia Advance Care Planning (AD ACP) to see if it helps people with dementia and their primary care team members have better discussions about their care preferences. The
Behavioural Intervention
Music for Alzheimer's Disease Prevention
Recruiting1 award3 criteria
Greensboro, North Carolina
This trial aims to see if listening to beat-accented music while exercising can help older adults with memory complaints to be more physically active. Participants will be divided into two groups - one group will exercise
Gene Therapy
Gene Therapy for Alzheimer's Disease
Recruiting1 awardPhase 1
Durham, North Carolina
This trial is a study to evaluate the safety of a gene therapy (LX1001) for people with a specific genetic risk for Alzheimer's disease. The therapy aims to convert a harmful gene variant to a protective one, potentially slowing the disease's progression.
Behavioral Intervention
Connect-Home for Alzheimer's Disease and Dementia
Recruiting1 award1 criteria
Chapel Hill, North Carolina
This trial is testing a program called Connect-Home ADRD that helps patients with Alzheimer's disease and dementias transition from nursing facilities to home or other care facilities. The main goal is to
Behavioural Intervention
Visual Consent for Clinical Trials
Recruiting1 award2 criteria
Chapel Hill, North Carolina
This trial will test a new consent process in three studies using a randomized control method. Research team members will start with the standard consent process and later switch to a visual key information page after training.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.